Medtronic plc. (NYSE:MDT) SVP Carol A. Surface sold 24,479 shares of the company’s stock in a transaction that occurred on Monday, March 5th. The shares were sold at an average price of $78.18, for a total value of $1,913,768.22. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink.
Medtronic plc. (NYSE MDT) traded down $1.18 during midday trading on Wednesday, hitting $82.30. The stock had a trading volume of 5,180,000 shares, compared to its average volume of 5,880,000. The company has a debt-to-equity ratio of 0.51, a current ratio of 2.43 and a quick ratio of 2.09. The company has a market cap of $113,130.00, a PE ratio of 40.34, a price-to-earnings-growth ratio of 2.36 and a beta of 0.97. Medtronic plc. has a 12-month low of $76.51 and a 12-month high of $89.72.
Medtronic (NYSE:MDT) last posted its quarterly earnings data on Tuesday, February 20th. The medical technology company reported $1.17 EPS for the quarter, topping the consensus estimate of $1.16 by $0.01. The firm had revenue of $7.37 billion during the quarter, compared to analyst estimates of $7.20 billion. Medtronic had a return on equity of 12.65% and a net margin of 9.44%. Medtronic’s revenue was up 1.2% on a year-over-year basis. During the same period in the prior year, the business posted $1.12 EPS. analysts expect that Medtronic plc. will post 4.75 EPS for the current fiscal year.
Large investors have recently bought and sold shares of the company. We Are One Seven LLC purchased a new stake in shares of Medtronic in the 4th quarter worth $104,000. BB&T Investment Services Inc. increased its stake in shares of Medtronic by 147.6% in the 4th quarter. BB&T Investment Services Inc. now owns 1,518 shares of the medical technology company’s stock worth $126,000 after purchasing an additional 905 shares in the last quarter. Blue Chip Partners Inc. purchased a new stake in Medtronic in the 3rd quarter worth $118,000. Quadrant Capital Group LLC increased its stake in Medtronic by 21.5% in the 2nd quarter. Quadrant Capital Group LLC now owns 1,639 shares of the medical technology company’s stock worth $114,000 after buying an additional 290 shares in the last quarter. Finally, Westwood Holdings Group Inc. purchased a new stake in Medtronic in the 2nd quarter worth $151,000. Hedge funds and other institutional investors own 80.79% of the company’s stock.
Several equities analysts recently issued reports on MDT shares. Bank of America raised Medtronic from a “neutral” rating to a “buy” rating in a research report on Tuesday, January 2nd. Royal Bank of Canada reaffirmed an “outperform” rating and issued a $92.00 price objective on shares of Medtronic in a research report on Wednesday, February 14th. SunTrust Banks set a $92.00 price objective on Medtronic and gave the company a “buy” rating in a research report on Sunday, November 19th. Jefferies Group reaffirmed a “buy” rating and issued a $99.00 price objective on shares of Medtronic in a research report on Thursday, November 23rd. Finally, Citigroup reaffirmed a “buy” rating and issued a $93.00 price objective (down from $100.00) on shares of Medtronic in a research report on Thursday, February 22nd. One equities research analyst has rated the stock with a sell rating, eight have issued a hold rating and sixteen have assigned a buy rating to the company. Medtronic presently has a consensus rating of “Buy” and a consensus price target of $91.50.
COPYRIGHT VIOLATION NOTICE: “Insider Selling: Medtronic plc. (MDT) SVP Sells 24,479 Shares of Stock” was reported by StockNewsTimes and is owned by of StockNewsTimes. If you are viewing this piece on another website, it was stolen and reposted in violation of US and international copyright laws. The correct version of this piece can be accessed at https://stocknewstimes.com/2018/03/14/medtronic-plc-mdt-svp-carol-a-surface-sells-24479-shares.html.
Medtronic Company Profile
Medtronic Public Limited Company (Medtronic) is a medical technology and services company. The Company develops, manufactures and markets its medical devices and technologies to hospitals, physicians, clinicians and patients in approximately 160 countries. The Company operates in four segments: Cardiac and Vascular Group, Minimally Invasive Technologies Group, Restorative Therapies Group and Diabetes Group.
Receive News & Ratings for Medtronic Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Medtronic and related companies with MarketBeat.com's FREE daily email newsletter.